Advicenne SA logo

ADVIC - Advicenne SA News Story

€7.02 -0.0  -0.6%

Last Trade - 07/08/20

Sector
Healthcare
Size
Small Cap
Market Cap £53.3m
Enterprise Value £39.4m
Revenue £1.50m
Position in Universe 557th / 852

BRIEF-Advicenne Announces FDA Clearance Of IND To Commence Pivotal Phase 3 Trial Of Adv7103

Wed 5th September, 2018 4:49pm
Sept 5 (Reuters) - Advicenne SA  ADVIC.PA :
    * ADVICENNE ANNOUNCES FDA CLEARANCE OF IND TO COMMENCE
PIVOTAL
PHASE 3 TRIAL OF ADV7103 FOR DISTAL RENAL TUBULAR ACIDOSIS
    * ADVICENNE SA - U.S. FDA CLEARED IND APPLICATION FOR
ADV7103,
ALLOWING CO TO FORMALLY INITIATE ARENA-2 PIVOTAL PHASE 3 TRIAL

Source text for Eikon:  ID:nBw8vWlsFa 
Further company coverage:  ADVIC.PA 

 ((Reuters.Briefs@thomsonreuters.com;))
© Stockopedia 2020, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.